Find out all about your favorite commercial!

Advertisers

Advertisers of the Stelara (Crohn's Disease) TV Spot, 'Unpredictable Symptoms: May Be Able to Help'

Stelara (Crohns Disease) TV commercial - Unpredictable Symptoms: May Be Able to Help
Stelara (Crohn's Disease)

Stelara is a company that specializes in developing treatments for Crohn's Disease, a type of inflammatory bowel disease that affects millions of people worldwide.Crohn's Disease is a chronic conditio...

What the Stelara (Crohns Disease) TV commercial - Unpredictable Symptoms: May Be Able to Help is about.

Stelara (Crohns Disease) TV commercial - Unpredictable Symptoms: May Be Able to Help

Stelara, a revolutionary treatment for Crohn's Disease, has captured the attention of patients and medical professionals around the world with its new TV spot, 'Unpredictable Symptoms: May Be Able to Help.' This thought-provoking commercial enlightens viewers about the debilitating nature of Crohn's Disease and offers hope for those who suffer from its unpredictable symptoms.

The TV spot begins with a series of visuals that depict the challenging and often painful aspects of living with Crohn's Disease. The viewer is transported into the daily life of a person with the condition, highlighting the toll it takes on their physical and emotional well-being. Images of a person clutching their stomach in pain, unable to eat a favorite meal, or missing out on social activities due to frequent flare-ups are potent reminders of the disease's impact.

As the visuals unfold, a soothing voiceover narrates the experience of those afflicted by Crohn's Disease. The voice speaks of the relentless nature of the symptoms, describing them as unpredictable and disruptive to daily life. It emphasizes the frustration and helplessness felt by patients as they navigate through the ups and downs of the disease.

Amidst these powerful images and words, the Stelara TV spot introduces its solution - Stelara, a breakthrough treatment that offers hope to those grappling with the debilitating effects of Crohn's Disease. The focus shifts to success stories, where individuals who have incorporated Stelara into their treatment plans share their experiences of finding relief and reclaiming their lives.

One patient speaks of how Stelara helped them regain control over their unpredictable symptoms, allowing them to enjoy meals, engage in social activities, and experience a renewed sense of normalcy. Another testifies to the positive impact of Stelara on their overall well-being, mentioning a reduction in flare-ups and an improvement in energy levels.

The commercial concludes with a call to action, urging viewers to consult their healthcare providers about the potential benefits of Stelara. Subtle disclaimers about potential side effects and individual results are communicated, ensuring a responsible and transparent approach to the advertisement.

Overall, the Stelara TV spot, 'Unpredictable Symptoms: May Be Able to Help,' offers a compelling narrative that sheds light on the challenges faced by individuals with Crohn's Disease. By highlighting the impact of this chronic condition and presenting Stelara as a potential solution, the commercial seeks to empower patients with hope and encourage them to explore options to manage their symptoms effectively.

Stelara (Crohns Disease) TV commercial - Unpredictable Symptoms: May Be Able to Help produced for Stelara (Crohn's Disease) was first shown on television on June 1, 2020.

Frequently Asked Questions about stelara (crohn's disease) tv spot, 'unpredictable symptoms: may be able to help'

In people with Crohn's, levels of these cytokines are elevated, causing long-term inflammation. By blocking these cytokines, Stelara reduces inflammation in the gastrointestinal tract. If you have Crohn's, you may need to try several types of medication before you find the best one for you.

Key IM-UNITI study findings for different dosing regimens found that 69.5 percent of patients who received 90 mg of Stelara every eight weeks were in clinical remission. Also, 62.9 percent of patients who received the same dose level every 12 weeks were in clinical remission.

45% of the overall population receiving STELARA ® were in clinical remission after 1 year of treatment.

A total of 506 patients received STELARA during the study period and 110 of these patients were dose escalated to receive STELARA every 4 weeks. The median time to interval shortening was 7.5 (IQR: 4.2-13.2) months after treatment initiation.

Generic Name: ustekinumab It can help to decrease the amount of plaques in plaque psoriasis, decrease the number of swollen/painful joints in psoriatic arthritis, and decrease symptoms such as abdominal pain/cramping and diarrhea in Crohn's disease and ulcerative colitis.

STELARA® is a prescription medicine used to treat: adults and children 6 years and older with moderate to severe psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).

Stelara requires one initial induction dose,* followed by maintenance doses every 8 weeks. Remicade requires three induction doses* at weeks 0, 2, and 6, followed by maintenance doses every 8 weeks.

Immune system suppressors

  • Azathioprine (Azasan, Imuran) and mercaptopurine (Purinethol, Purixan). These are the most widely used immunosuppressants for treatment of inflammatory bowel disease.
  • Methotrexate (Trexall). This drug is sometimes used for people with Crohn's disease who don't respond well to other medications.

Stelara requires one initial induction dose,* followed by maintenance doses every 8 weeks. Remicade requires three induction doses* at weeks 0, 2, and 6, followed by maintenance doses every 8 weeks.

Stelara Coupons, Prices, and Savings Card Learn more about ustekinumab intravenous . This is a brand name drug and a generic may be available. The average cost for 1 Syringe, 1ml of 90mg/ml each, is $31,832.00.

Stelara is used to treat some forms of ulcerative colitis or Crohn's disease in adults. For this purpose, the recommended maintenance dosage of Stelara is a 90-mg subcutaneous injection every 8 weeks.

There's currently no cure for Crohn's disease, but treatment can control or reduce the symptoms and help stop them coming back.

Videos

Watch Stelara (Crohn's Disease) TV Commercial, 'Unpredictable Symptoms: May Be Able to Help'

Unfortunately we were unable to find any suitable videos in the public domain. Perhaps the video of this TV commercial has not been preserved. If you know the link to this commercial, you can send it to us using a special form.

Actors

Actors who starred in Stelara (Crohn's Disease) TV Spot, 'Unpredictable Symptoms: May Be Able to Help'

Jessica Cannon photo
Matt Giroveanu photo
Agenices

Agenices of the Stelara (Crohn's Disease) TV Spot, 'Unpredictable Symptoms: May Be Able to Help'

Stelara (Crohns Disease) TV commercial - Unpredictable Symptoms: May Be Able to Help
OMD

OMD (Optimum Media Direction) is a global media agency with a presence in over 100 countries. The company was founded in 1991 and is headquartered in London, UK. OMD offers a wide range of services, i...

Products

Products Advertised

Stelara (Crohn's Disease) Stelara
TV commercials

Similar commercials

Yeti, Set, Go! TV Spot, 'Meatballs!'
TRELEGY TV Spot, 'Make a Stand'
1031 November 1, 2020
Android TV Spot, 'Friends Furever'
872 February 6, 2015
Target TV Spot, 'One Great Day' Song by Keala Settle
Dupixent TV Spot, 'Better Breathing'
Nerf DinoSquad TV Spot, 'Unleash Your Inner Beast'
Dupixent TV Spot, 'Du More: Yard Work & Team Work'
Valpak TV Commercial 'School Play'
1190 October 16, 2012
Nerf Elite 2.0 TV Spot, 'Ready for Any Mission'
Arcade1Up TV Spot, 'Bring the Arcade Home'
Rockboard TV Spot, 'No Gas or a Battery'
Yvolution Fliker Scooters TV Spot, 'Warehouse Tricks'